Top Story

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014

BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he participated in at the Cardiometabolic Health Congress on PCSK9 as a target for cholesterol-lowering therapy.

Davidson, clinical professor of medicine and director of the lipid clinic at the University of Chicago Pritzker School of Medicine, noted that in less than a decade since discovering that PCSK9 deficiencies led to reduced LDL cholesterol and CV risk, multiple clinical trials have indicated the effectiveness of PCSK9 as an LDL-lowering therapy. He also addressed the lowering of LDL as a target of therapy, and acknowledged that several outcome trials assessing this possibility are currently underway.

figure Meeting News Coverage

Expert examines contribution of aldosterone in obesity-related hypertension

October 24, 2014
BOSTON — At the Cardiometabolic Health Congress, Colleen M. Majewski, MD, discussed the link between elevated aldosterone and obesity-related hypertension, and…
figure Meeting News Coverage

Exploration of devices to treat resistant hypertension in progress

October 24, 2014
BOSTON — Despite recent setbacks, research and development on device therapy for treatment-resistant hypertension is proceeding, a hypertension expert said at the…
figure Meeting News Coverage

Novel oral anticoagulants vs. warfarin: The debate continues

October 24, 2014
BOSTON — The burden of stroke related to atrial fibrillation is substantial and there is ongoing debate about the best therapy for stroke prevention in patients…
CME
figure

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
figure

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he…
More »
CME
figure

Obesity Consults: Volume 1, Number 4

This activity is supported by an educational grant from Vivus.

Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States…
More »

Filter By:

figure Meeting News Coverage Video

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he participated in at the…
figure Meeting News Coverage

Expert examines contribution of aldosterone in obesity-related hypertension

October 24, 2014
BOSTON — At the Cardiometabolic Health Congress, Colleen M. Majewski, MD, discussed the link between elevated aldosterone and obesity-related…
figure Meeting News Coverage

Exploration of devices to treat resistant hypertension in progress

October 24, 2014
BOSTON — Despite recent setbacks, research and development on device therapy for treatment-resistant hypertension is proceeding, a hypertension…
figure Meeting News Coverage

Novel oral anticoagulants vs. warfarin: The debate continues

October 24, 2014
BOSTON — The burden of stroke related to atrial fibrillation is substantial and there is ongoing debate about the best therapy for stroke…
figure Meeting News Coverage

Experts debate long-term DAPT for patients with stents

October 24, 2014
BOSTON — While conceding that definitive research has yet to emerge, two experts at the Cardiometabolic Health Congress debated the merits of…
figure Meeting News Coverage Video

Experts tackle racial, ethnic disparities in cardiometabolic health

October 23, 2014
BOSTON — In this video, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at Tulane University School of Medicine in New Orleans…
figure Meeting News Coverage

Cardiometabolic Health Congress highlights latest research on CVD, diabetes, obesity

October 23, 2014
BOSTON — The latest innovative research in diabetes, hypertension, lipids, obesity and thrombosis was analyzed by experts at the…
figure Meeting News Coverage

New trials underway to explore impact of anti-inflammatory therapy on CV events

October 23, 2014
BOSTON — Multiple studies have suggested that measures of inflammatory biomarkers may be predictive of CV events, and the question remains…
figure Meeting News Coverage

Misinterpretation of cholesterol, risk-assessment guidelines may produce unintended consequences

October 23, 2014
BOSTON — Misinterpretation of the 2013 American College of Cardiology/American Heart Association guidelines on cholesterol management and CV…
figure Meeting News Coverage

Despite perceived differences, international hypertension guidelines 'mostly similar'

October 23, 2014
BOSTON — Despite recent controversy over BP targets for adults aged 60 years and older, international guidelines for hypertension are…
More Headlines »